Evolent Health, Inc. (EVH)
USD 8.96
(3.53%)
USD 8.96
(3.53%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.61 Billion USD | 68.35% |
| 2022 | 957.87 Million USD | 31.97% |
| 2021 | 725.82 Million USD | -3.3% |
| 2020 | 750.58 Million USD | 31.92% |
| 2019 | 568.96 Million USD | 6.76% |
| 2018 | 532.92 Million USD | 100.05% |
| 2017 | 266.39 Million USD | -7.41% |
| 2016 | 287.72 Million USD | 255.5% |
| 2015 | 80.93 Million USD | 100.6% |
| 2014 | 40.34 Million USD | -43.12% |
| 2013 | 70.93 Million USD | 538.85% |
| 2012 | 11.1 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 1.59 Billion USD | -1.05% |
| 2024 Q2 | 1.42 Billion USD | -10.93% |
| 2023 Q4 | 1.61 Billion USD | 2.48% |
| 2023 FY | 1.61 Billion USD | 68.35% |
| 2023 Q2 | 1.55 Billion USD | 5.85% |
| 2023 Q3 | 1.57 Billion USD | 1.28% |
| 2023 Q1 | 1.46 Billion USD | 53.23% |
| 2022 Q4 | 957.87 Million USD | 6.07% |
| 2022 FY | 957.87 Million USD | 31.97% |
| 2022 Q3 | 903.04 Million USD | 30.72% |
| 2022 Q2 | 690.82 Million USD | -5.1% |
| 2022 Q1 | 727.94 Million USD | 0.29% |
| 2021 Q3 | 646.04 Million USD | -4.88% |
| 2021 Q1 | 688.28 Million USD | -8.3% |
| 2021 Q2 | 679.17 Million USD | -1.32% |
| 2021 FY | 725.82 Million USD | -3.3% |
| 2021 Q4 | 725.82 Million USD | 12.35% |
| 2020 Q1 | 603.68 Million USD | 6.1% |
| 2020 Q3 | 737.04 Million USD | 18.25% |
| 2020 Q4 | 750.58 Million USD | 1.84% |
| 2020 FY | 750.58 Million USD | 31.92% |
| 2020 Q2 | 623.27 Million USD | 3.24% |
| 2019 Q4 | 568.96 Million USD | -3.49% |
| 2019 FY | 568.96 Million USD | 6.76% |
| 2019 Q1 | 479.24 Million USD | -10.07% |
| 2019 Q3 | 589.55 Million USD | 16.63% |
| 2019 Q2 | 505.5 Million USD | 5.48% |
| 2018 FY | 532.92 Million USD | 100.05% |
| 2018 Q4 | 532.92 Million USD | 94.43% |
| 2018 Q3 | 274.1 Million USD | 1.43% |
| 2018 Q2 | 270.23 Million USD | 7.5% |
| 2018 Q1 | 251.39 Million USD | -5.63% |
| 2017 Q2 | 243.9 Million USD | -5.36% |
| 2017 Q3 | 243.25 Million USD | -0.27% |
| 2017 FY | 266.39 Million USD | -7.41% |
| 2017 Q1 | 257.7 Million USD | -10.43% |
| 2017 Q4 | 266.39 Million USD | 9.51% |
| 2016 FY | 287.72 Million USD | 255.5% |
| 2016 Q1 | 84.4 Million USD | 4.28% |
| 2016 Q2 | 84.65 Million USD | 0.3% |
| 2016 Q4 | 287.72 Million USD | 214.72% |
| 2016 Q3 | 91.42 Million USD | 7.99% |
| 2015 Q1 | 68.72 Million USD | 70.32% |
| 2015 Q2 | 91.13 Million USD | 32.61% |
| 2015 Q4 | 80.93 Million USD | -32.63% |
| 2015 Q3 | 120.12 Million USD | 31.82% |
| 2015 FY | 80.93 Million USD | 100.6% |
| 2014 FY | 40.34 Million USD | -43.12% |
| 2014 Q1 | - USD | -100.0% |
| 2014 Q4 | 40.34 Million USD | -20.37% |
| 2014 Q3 | 50.66 Million USD | 0.0% |
| 2013 FY | 70.93 Million USD | 538.85% |
| 2013 Q4 | 29.32 Million USD | 0.0% |
| 2012 FY | 11.1 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Well Corporation | 109.51 Million USD | -1372.445% |
| Doximity, Inc. | 177.97 Million USD | -806.076% |
| MultiPlan Corporation | 5.39 Billion USD | 70.118% |
| Phreesia, Inc. | 119.63 Million USD | -1247.928% |
| Teladoc Health, Inc. | 2.06 Billion USD | 21.957% |
| Veeva Systems Inc. | 1.26 Billion USD | -27.368% |